C-EHRN provides advice to reduce the harms associated with the unintentional consumption of synthetic cannabinoids in contexts where drug checking services are not available.
The Center on Drug Policy Evaluation outlines drug policy reform and harm reduction priorities they believe the Biden administration should immediately act upon.
FEDITO BLX and IDPC make recommendations for Belgium's UPR, focusing on adopting a public health approach, decriminalising people who use drugs and providing a clear legal framework for drug consumption rooms.